Local treatment of fungal infections caused by naftifin-sensitive pathogens: fungal infections of the skin and skin folds; interdigital mycoses; fungal nail infections (onychomycosis); skin candidiasis; pityriasis versicolor; inflammatory dermatomycosis, with or without itching; mycosis of the external auditory canal.
active substance: naftifine hydrochloride; 1 ml of solution contains naftifine hydrochloride in terms of 100% dry matter 10 mg; excipients: propylene glycol, ethanol 96%, purified water.
Local treatment of fungal infections caused by naftifine-sensitive pathogens: – fungal infections of the skin and skin folds; – interdigital mycoses; – fungal nail infections (onychomycosis); – skin candidiasis; – herpes zoster; – inflammatory dermatomycoses, with or without itching.
Hypersensitivity to naftifine, propylene glycol or to any other components of the drug. The drug should not be applied to the wound surface. Do not use for eye treatment.
Method of application and dosage. Estezifin solution should be applied to the affected skin surface once a day after thorough cleansing and drying, covering approximately 1 cm of healthy skin around the affected area. Duration of treatment: for dermatomycoses – 2-4 weeks (if necessary – up to 8 weeks); with candidiasis – 4 weeks; for nail infections – up to 6 months. At fungal diseases of nails the drug is recommended to be applied 2 times a day. Before the first application, the affected part of the nail should be removed as much as possible with scissors or a nail file (to facilitate this procedure, the nails can be treated with a special emollient on the advice of a doctor). To prevent recurrence, treatment with the drug should be continued for at least 2 weeks after the disappearance of the main symptoms of the disease.
There are insufficient data on the effectiveness and safety of the drug in children, so it is not recommended to prescribe Estezifin to patients in this age group.